Bcl3 was first identified as a putative proto-oncogene [108] and while overexpression has been associated with some cancer types [109], BCL-3 also has an critical role in limiting NF-κB transcriptional activity in immune cells and promoting endotoxin tolerance to LPS [110,111]. The gene discussed is NFKB1; the disease is cancer.